C. Sansom

发表

Molecular mechanics analysis of inhibitor binding to HIV-1 protease.

I. Weber, J. Wu, C. Sansom, 1992, Protein engineering.

Energy calculations and analysis of HIV-1 protease-inhibitor crystal structures.

A Wlodawer, J Richelle, A. Wlodawer, 1994, Protein engineering.

The lipocalin protein family: structural and sequence overview.

D R Flower, A. North, D. Flower, 2000, Biochimica et biophysica acta.

Protein structure by design

C. Sansom, 1997 .

Are bacterial vaccine antigens T-cell epitope depleted?

D. Moss, M. Halling-Brown, M. Davies, 2008, Trends in immunology.

Studies of the membrane topology of the rat erythrocyte H+/lactate cotransporter (MCT1).

C. Sansom, A. Halestrap, R. Poole, 1996, The Biochemical journal.

Systems Biology: Will it work?

C. Sansom, 2005 .

Forty winks: molecular basis of sleep disorders.

C. Sansom, 2000, Molecular medicine today.

Proteins accessible to immune surveillance show significant T-cell epitope depletion: Implications for vaccine design.

V. Brusic, D. Moss, D. Flower, 2009, Molecular immunology.

Mutational analysis and molecular modelling of an amino acid sequence motif conserved in antiporters but not symporters in a transporter superfamily.

C. Sansom, J. Griffith, M. Varela, 1995, Molecular membrane biology.

H+/sugar-symporter-uniporter family

C. Sansom, J. Griffith, 1998 .

Binding protein-dependent peptide transporter family

C. Sansom, J. Griffith, 1998 .

A step towards gene therapy for CF.

C. Sansom, 1999, Molecular medicine today.

Open Research Adenine Quadruplexes Show Surprising Stability: Potential Implications for SARS-CoV-2

Nicholas P. Power, C. Sansom, P. Ghesquiere, 2022 .

White transporter family

C. Sansom, J. Griffith, 1998 .

Aggregation inhibitors: hope for Huntington's?

C. Sansom, 1999, Molecular medicine today.

Making sense of the human proteome.

C. Sansom, 1999, Molecular medicine today.

Anti-tumour imidazotetrazines. Part XXI. Mitozolomide and temozolomide: probes for the major groove of DNA.

M. Stevens, C. Sansom, C. Schwalbe, 1990, Anti-cancer drug design.

Vacuolar ATPase family

C. Sansom, J. Griffith, 1998 .

A large‐scale computational study of inhibitor risk in non‐severe haemophilia A

D. Moss, A. Shepherd, C. Sansom, 2015, British journal of haematology.

Antitumor imidazotetrazines. 25. Crystal structure of 8-carbamoyl-3-methylimidazo[5,1-d]-1,2,3,5-tetrazin-4(3H)-one (temozolomide) and structural comparisons with the related drugs mitozolomide and DTIC.

M. Stevens, C. Sansom, C. Schwalbe, 1992, Journal of medicinal chemistry.

Diffuse X-Ray scattering from molecular crystals

D. Moss, G. Harris, C. Sansom, 2003 .

Structural studies on bio-active compounds. Part XV. Structure-activity relationships for pyrimethamine and a series of diaminopyrimidine analogues versus bacterial dihydrofolate reductase.

M. Stevens, R. Griffin, C. Sansom, 1989, Biochimica et biophysica acta.

Introduction: Proteomics and Protein-Protein Interactions: Biology, Chemistry, Bioinformatics, and Drug Design

Gabriel Waksman, Clare Sansom, G. Waksman, 2005 .

2010 ISCB Overton Prize Awarded to Steven E. Brenner

Clare Sansom, B. J. Morrison McKay, C. Sansom, 2010, PLoS Comput. Biol..

P-Glycoprotein transporter family

C. Sansom, J. Griffith, 1998 .

Structural analysis and classification of lipocalins and related proteins using a profile-search method.

A. North, L. Sawyer, C. Sansom, 1994, Biochimica et biophysica acta.

Database Searching with DNA and Protein Sequences: An Introduction

Clare Sansom, C. Sansom, 2000, Briefings Bioinform..

A role for Borna disease virus in schizophrenia?

C. Sansom, 2000, Molecular medicine today.

In search of the nature of specific nucleic acid-protein interactions.

Z. Benyó, C. Sansom, J. Biro, 2005, Acta physiologica Hungarica.

A Novel Predictive Technique for the MHC Class II Peptide-Binding Interaction

Claude Beazley, Matthew N Davies, David S Moss, 2003, Molecular medicine.

The ImmunoGrid Simulator: How to Use It

Vladimir Brusic, Ferdinando Chiacchio, Adrian J. Shepherd, 2009, CIBB.

the human immune system at a natural scale ImmunoGrid: towards agent-based simulations of

Patrice Duroux, Marie-Paule Lefranc, Ping Zhang, 2010 .

Immunomodulation in DNA damage and repair.

C. Sansom, 2000, Molecular medicine today.

Cost-effective carbohydrate synthesis permits large-scale production of an anti-inflammatory drug.

C. Sansom, 1998, Molecular medicine today.

Molecular modelling and site-directed mutagenesis of the active site of endothelin-converting enzyme.

C. Sansom, A. Turner, M. Hoang, 1998, Protein engineering.

The Transporter Factsbook

C. Sansom, J. Griffith, 1997 .

ImmunoGrid: towards agent-based simulations of the human immune system at a natural scale†

Massimo Bernaschi, Marie-Paule Lefranc, Ole Lund, 2010, Philosophical Transactions of the Royal Society A: Mathematical, Physical and Engineering Sciences.

Na+/neurotransmitter symporter family

C. Sansom, J. Griffith, 1998 .

Computer applications in the biomolecular sciences. Part 1: Molecular modelling

Clare Sansom, Craig A. Smith, C. Sansom, 1998 .

Mice illuminate the pathways to lupus.

C. Sansom, 1999, Molecular medicine today.

Drugs Targeted at HIV — Successes and Resistance

A. Wlodawer, C. Sansom, 2002 .

SysMIC: A Blueprint for Interdisciplinary Online Training in the Life Sciences

Stephen Gilmore, David Crowe, Gerold Baier, 2016 .

A future vaccine for diabetes?

C. Sansom, 2001, Drug Discovery Today.

Using the transcriptome to annotate the genome revisited: application of massively parallel signature sequencing (MPSS).

M. Gardner, V. Nene, T. Shah, 2006, Gene.

Peroxisomal membrane transporter family

C. Sansom, J. Griffith, 1998 .

The ninth International Conference of Anticancer Research, 6–10 October 2014, Sithonia, Greece

C. Sansom, 2014, Ecancermedicalscience.

A computational Grid framework for immunological applications

Adrian J. Shepherd, Mark D. Halling-Brown, Clare E. Sansom, 2009, Philosophical Transactions of the Royal Society A: Mathematical, Physical and Engineering Sciences.

The Grid revisited

Clare Sansom, C. Sansom, 2008 .

Sugar phosphate transporter family

C. Sansom, J. Griffith, 1998 .

Na+/glucose symporter family

C. Sansom, J. Griffith, 1998 .

Patient‐Specific Modelling in Drug Design, Development and Selection Including its Role in Clinical Decision‐Making

Nour Shublaq, Peter V Coveney, Clare Sansom, 2013, Chemical biology & drug design.

- Na + /Ca 2+ exchanger family

C. Sansom, J. Griffith, 1998 .

A Fugu-Human Genome Synteny Viewer: web software for graphical display and annotation reports of synteny between Fugu genomic sequence and human genes.

Greg Elgar, Mark Halling-Brown, Clare Sansom, 2004, Nucleic acids research.

Identification of the HLA-DM/HLA-DR interface.

D. Moss, D. Flower, M. Davies, 2008, Molecular immunology.

Cystic fibrosis transmembrane conductance regulator family

C. Sansom, J. Griffith, 1998 .

Are bacterial vaccine antigens T-cell epitope depleted?

D. Moss, M. Halling-Brown, M. Davies, 2008, Trends in immunology.

Evolution goes for GOLD in silico

Clare Sansom, C. Sansom, 1997, Nature Biotechnology.

Crystal structure and molecular modelling of the antimicrobial drug pentamidine

Malcolm F. G. Stevens, Carl H. Schwalbe, M. Stevens, 1989 .

Use of Graphics Workstations to Illustrate Protein and Nucleic Acid Structure: A Description of Three Modelling Experiments Carried out by Secondyear Undergraduates

C. E. Sansom, D. A. Waller, Aj Geddes, 1996 .